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During first merogony Eimeria bovis forms large macromeronts in endothelial host cells containing >120 000
merozoites I. During multiplication, large amounts of cholesterol are indispensable for the enormous offspring
membrane production. Cholesterol auxotrophy was proven for other apicomplexan parasites. Consequently they
scavenge cholesterol from their host cell apparently in a parasite-specific manner. We here analyzed the influence
of E. bovis infection on endothelial host cell cholesterol metabolism and found considerable differences to other
coccidian parasites. Overall, free cholesterol significantly accumulated in E. bovis infected host cells. Furthermore, a
striking increase of lipid droplet formation was observed within immature macromeronts. Artificial host cell lipid
droplet enrichment significantly improved E. bovis merozoite I production confirming the key role of lipid droplet
contents for optimal parasite proliferation. The transcription of several genes being involved in both, cholesterol de
novo biosynthesis and low density lipoprotein-(LDL) mediated uptake, was significantly up-regulated at a time in
infected cells suggesting a simultaneous exploitation of these two cholesterol acquisition pathways. E. bovis scavenges
LDL-derived cholesterol apparently through significantly increased levels of surface LDL receptor abundance and LDL
binding to infected cells. Consequently, LDL supplementation significantly improved parasite replication. The
up-regulation of the oxidized LDL receptor 1 furthermore identified this scavenger receptor as a key molecule
in parasite-triggered LDL uptake. Moreover, cellular cholesterol processing was altered in infected cells as
indicated by up-regulation of cholesterol-25-hydroxylase and sterol O-acyltransferase. Overall, these results
show that E. bovis considerably exploits the host cell cholesterol metabolism to guarantee its massive intracellular
growth and replication.Introduction
Eimeria bovis represents one of the most pathogenic
Eimeria species causing cattle coccidiosis [1]. During its
long-lasting intracellular first merogony (14–18 days of
duration) E. bovis forms large macromeronts of up to
400 μm in size containing ≥120 000 merozoites I within
a parasitophorous vacuole (PV) in host endothelial cells
[2]. Given that the invading sporozoite stage alone
cannot provide all components necessary for this nutri-
ent and energy demanding process, the parasite needs to
scavenge molecules from the host cell. Especially for the* Correspondence: penny_hamid@ugm.ac.id
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Coccidian parasites have been described as auxotrophic
in their capability to synthesize cholesterol by themselves
[3–9]. Thus, cholesterol auxotrophy was reported for
Toxoplasma gondii and Cryptosporidium parvum [4,7,9].
In consequence these parasites scavenge cholesterol from
their host cell thereby exploiting different cellular path-
ways. Interestingly, different cholesterol auxotrophic para-
sites appear to follow different strategies of cholesterol
scavenge suggesting the modulation of host cell cholesterol
metabolism as a parasite-specific and/or host cell-specific
process. Coppens et al. [4] experimentally proved T. gondii
as deficient in cholesterol biosynthesis and showed that this
parasite scavenges cholesterol from its host cell. However,is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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fected host cell types. Thus, in contrast to macrophages
[10], T. gondii exclusively utilized cholesterol derived from
internalized LDL particles in CHO cells [4] whilst tran-
scriptomic data on infected fibroblasts indicated an
up-regulation of molecules being involved in the mevalo-
nate pathway [11]. The pivotal role of cholesterol was also
proven by exogenously supplied cholesterol which im-
proved T. gondii replication [4]. Cholesterol is inserted in
the parasite plasma membrane, the parasitophorous vacu-
olar membrane (PVM), sequestered in cholesterol-rich
organelles in T. gondii-infected host cells and is further-
more esterified for lipid droplet deposition [4,12–14].
Accordingly, host and parasite esterification activity was
shown to be essential for T. gondii intracellular growth [15].
Correspondingly, T. gondii infection leads to enhanced
cytoplasmic lipid droplet formation in skeletal muscle cell
cultures [16].
By far less data on cholesterol scavenge is available from
other coccidian parasites. Cryptosporidium parvum mainly
acquires cholesterol from LDL particles and from micelles
being internalized by the infected enterocytes but only to a
minor degree from host cellular de novo-synthesis [7]. The
non-coccidian but apicomplexan parasite Plasmodium yoe-
lii in principle salvages cholesterol in infected hepatocytes
from both host cellular pathways, [6,17] although host
cellular cholesterol acquisition does not appear to be
essential for its optimal proliferation [6]. The authors
interpret these results by a moderate parasitic need of
sterols and by an adaptive reaction to cholesterol-restricted
conditions in terms of alternative source utilization.
Abundant lipid droplet formation was also reported for
P. berghei- or P. falciparum-infected host cells [18,19],
but no cholesteryl ester formation was detected in Plas-
modium-infected cells, implying a lack of lipid storage
activity [19–22] which may argue for a continuous
cholesterol acquisition from the host cell as hypothe-
sized by Coppens [9].
To date, no detailed analyses on cholesterol acquisi-
tion exist for any Eimeria species. All farm animals kept
under conventional farming conditions unavoidably are
exposed to Eimeria spp. infections worldwide [1,23] and
infection-induced impaired animal performance, mortal-
ity and anticoccidial treatment costs generally result in
considerable economic losses [1,24]. As an obligate intra-
cellular protozoa residing within a PV, Eimeria spp.
require cholesterol not only for PV establishment and host
cell (membrane) enlargement (especially in macromeront-
forming species) but in particular for massive offspring
production (>120 000 merozoites I in case of E. bovis).
Consequently, global transcriptomic approaches on in-
fected endothelial host cells have indicated that E. bovis is
in need for cholesterol for its successful replication [25].
In addition, recent inhibitor analyses indicated a pivotalrole of the host cellular cholesterol de novo synthesis for
parasite replication since treatments of E. bovis-infected
cells with inhibitors of the mevalonate pathway significantly
blocked parasite proliferation [26]. However, detailed ana-
lyses on this topic are lacking so far. Therefore we here
conducted analyses on E. bovis-induced alterations of the
mevalonate pathway, on lipid droplet formation and on
LDL-mediated cholesterol internalization and showed that
apparently this parasite applies comparable but also dif-
ferent strategies compared to other coccidian species to
meet its needs for cholesterol for successful macromer-
ont formation.
Materials and methods
Parasite
The E. bovis strain H used in the present study was ini-
tially isolated from the field in Northern Germany [27]
and maintained by passages in parasite-free male
Holstein Friesian calves [28]. All animal procedures were
performed according to the Justus Liebig University
Animal Care Committee guidelines, approved by the
Ethic Commission for Experimental Animal Studies of
the State of Hesse (Regierungspräsidium Giessen, GI 18/
10 No A37/2011, JLU-No 494) and in accordance to the
current German Animal Protection Laws.
For oocysts production, calves were infected orally at the
age of 10 weeks with 3 × 105 sporulated E. bovis oocysts.
The oocysts were isolated from the faeces beginning 18
days post infection (pi) according to the method of Jackson
[29]. The sporulation of oocysts was achieved by incubation
in a 2% (w/v) potassium dichromate (Merck) solution at
room temperature (RT). Sporulated oocysts were stored in
2% (w/v) potassium dichromate solution at 4 °C until fur-
ther use. Sporozoites were excysted from sporulated oo-
cysts as previously described [30]. Free sporozoites were
washed three times in phosphate buffered-solution (PBS)
and counted in a Neubauer chamber.
Host cells and Eimeria bovis host cell infections
Primary bovine umbilical vein endothelial cells (BUVEC)
were isolated according to Jaffe et al. [31]. Umbilical
cords were collected under aseptic conditions from ani-
mals born by sectio caesaria and kept at 4 °C in 0.9%
HBSS-HEPES buffer (pH 7.4, Gibco) supplemented with
1% penicillin (500 U/mL, Sigma-Aldrich) and strepto-
mycin (50 μg/mL, Sigma-Aldrich) until use. For the
isolation of endothelial cells, 0.025% collagenase type II
(Worthington Biochemical Corporation) suspended in
Pucks solution (Gibco) was infused into the lumen of
the ligated umbilical vein and incubated for 20 min at
37 °C in 5% CO2 atmosphere. After gently massaging
the umbilical vein, the cell suspension was collected
and supplemented with 1 mL fetal calf serum (FCS,
Gibco) in order to inactivate the collagenase. After two
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pended in complete endothelial cell growth medium
(ECGM, PromoCell), plated in 25 cm2 tissue plastic
culture flasks (Greiner) and kept at 37 °C in 5% CO2
atmosphere. BUVEC were cultured in modified ECGM
medium (EGCM, PromoCell, diluted 0.3× in M199
medium, Sigma-Aldrich) with medium changes every
2–3 days. BUVEC cell layers were used for infection
after 1–2 passages in vitro.
BUVEC layers in 24-well or 25 cm2-flask formats were
infected at 80–90% confluency with 2 × 104 or 1.5 × 106 E.
bovis sporozoites, respectively. Culture medium was chan-
ged 24 h after parasite infection and thereafter every third
day. Merozoites I were collected from cell culture super-
natants from days 17–20 pi onwards and washed three
times in PBS (600 × g, 15 min) before further use.
Staining of cholesterol and lipid droplets
For staining of intracellular stages (1, 8, 14 and 17 days pi),
BUVEC were grown on cover slips and infected, whereas
invasive stages (sporozoites and merozoites I) were directly
dropped onto poly-L-lysine coated coverslips. Specimens
were washed with PBS, fixed in 4% paraformaldehyde
(10 min), washed three times in PBS and incubated in
1% glycine PBS (10 min) to quench non-specific
signals, followed by three washings in PBS. To detect
free cholesterol, the samples were stained by filipin
(0.05 mg/mL in PBS containing 10% FCS, Sigma-
Aldrich, 2 h, in the dark, RT). For neutral lipid/lipid
droplet visualization the cells were stained in Nile Red
(1:1000, Cayman Chemical, 15 min, RT, in the dark) or
with Bodipy 493/503 (1 μg/mL, Life Technologies; 10
min, RT, in the dark). All samples were washed in PBS,
mounted in Prolong antifading mounting medium (Life
Technologies) and analyzed using an inverted fluores-
cence microscope or confocal microscope applying the
UV filter set for filipin (340–380 nm excitation, 430 nm
pass filter) or FITC filter settings for Nile red and
Bodipy 493/503. For an alternative LD staining, osmium
tetroxide staining [32] was performed with modifica-
tion. Therefore, cells were washed four times in PBS,
fixed (2% paraformaldehyde containing 0.1% glutaralde-
hyde, EM grade, Sigma-Aldrich, RT, 30 min) and osmium
tetroxide-stained (0.1%, Sigma-Aldrich, RT, 30 min). The
samples were washed three times in PBS, mounted in PBS
and analyzed under bright field conditions.
Total cholesterol measurement
Total lipid extractions from E. bovis-infected (4, 8 and
17 days pi) and control BUVEC (n = 7) were performed
in hexane:isopropanol according to Hara and Radin
[33]. The cells were washed twice in ice-cold PBS, tryp-
sinized and washed again (400 × g, 10 min). The total
cell numbers were counted using a Neubauer chamber.Hexane:isopropanol (3:2, v/v) was added to the cell
pellet. Cells were disrupted for 10 min in a Tissue Lyser
(Qiagen, Hilden, Germany) using stainless steel beads.
The samples were centrifuged (8000 × g, 1 min) and the
supernatants were collected. The extraction was repeated
once for each sample. The supernatants were then
combined and dried manually under gentle liquid nitrogen
stream. The total lipid extracts were reconstituted in
500 μL isopropanol:NP40 (9:1, v/v) followed by sonication
in a waterbath (RT, 30 min). 5 μL of each sample
were pre-treated with catalase [(5 μL of 0.5 mg/mL)
in 40 μL of 1X reaction buffer (37 °C, 15 min)] in
96-well black clear-bottom plates (Greiner Bio-One)
to reduce background fluorescence of peroxides in
the solvents [34] before the enzyme cocktail of the
Amplex-red kit (Life Technologies) was added. Chol-
esterol standards (Sigma-Aldrich; 10, 5, 2.5, 1.25,
0.625 and 0.325 μM) and blanks (solvent only) were in-
cluded in each experiment. Fifty microliters of enzyme mix-
ture (0.1 M potassium phosphate buffer, pH 7.4; 0.25 M
NaCl, 5 mM cholic acid, 0.1% Triton X-100, 0.3 U/mL
cholesterol oxidase, cholesterol esterase, 1.3 U/mL HRP,
and 0.4 mM ADHP) were added and incubated (37 °C, 15
min). Resorufin formation was measured by fluorescence
intensities (excitation wavelength of 530 nm, emission
wavelength of 580 nm) in the Varioskan Flash Multimode
Reader (Thermo Scientific). Total cholesterol of the sam-
ples was extrapolated to the values of the cholesterol stand-
ard. The total cholesterol content of each sample was
normalized to its total cell number counts.Quantitative analysis of lipid droplet accumulation in
infected BUVEC
E. bovis-infected and control BUVEC (n = 3) were trypsi-
nized at days 8, 17 and 21 pi and pelleted in PBS
(400 × g, 3 min, 4 °C). The resuspended cells were
stained with Bodipy 493/503 (10 min, on ice) and
washed twice with 1 ml PBS (400 × g, 3 min, 4 °C). The
cells were transferred to 5-mL FACS tubes containing
200 μL of PBS and were processed in a FACS Calibur
flow cytometer (BD Biosciences, Heidelberg, Germany)
by laser excitation at 488 nm (FL1-H channel). Flow cy-
tometry data were acquired by the BD CellQuest Pro
software.Cholesterol, LDL and lipid droplet enrichment
For cholesterol enrichment, both, cholesterol and desmos-
terol (both Sigma-Aldrich) dissolved in ethanol were con-
tinuously added to BUVEC cultures (n = 5) at 5 μM final
concentration. Although not being physiological the admin-
istration of cholesterol at low concentration (in ethanol)
according to Xu et al. [35] was chosen to reduce its toxicity
in long-term application. Supplementation of cholesterol
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culture in our hands owing to its high cytotoxicity.
For LDL enrichment, LDL (Sigma-Aldrich, 10 mg/mL
final concentration) was supplemented to E. bovis-infected
BUVEC (n = 5) from 10 days pi onwards. To artificially en-
hance lipid droplet formation in host cells, oleic acid
(Sigma-Aldrich) was supplemented in BSA formulation
complexes [36] to the cell culture medium. Direct conju-
gation was performed by mixing oleic acid-free BSA
(fraction V, Roth) with oleic acid at the molar ratio of 6:1
(oleic acid:BSA). BUVEC (n = 3) were treated with 5 μM
oleic acid/BSA complexes for an induction period of 1 h,
and thereafter continuously with 2.5 μM to prevent tox-
icity. Treatments were repeated every second day from
8 days pi onwards.
Low density lipoprotein (LDL) binding assay
The binding of LDL to receptors on the surface of in-
fected cells and non-infected controls was estimated
using Bodipy-labelled LDL (Life Technologies). Therefore,
E. bovis-infected BUVEC (15 days pi) were cultivated in
FCS-free endothelial cell basal medium (PromoCell)
supplemented with 10% lipoprotein deficient-serum
(Sigma-Aldrich) for 36–48 h prior to medium supple-
mentation with Bodipy-labelled LDL (10 μg/mL). The
cells were incubated for 1 h at 4 °C followed by 4 h at
37 °C and also 3 h, 5 h for fluorescence microscopy.
For qualitative analyses the cells were washed in PBS,
fixed (4% paraformaldehyde, 10 min) and mounted in
Prolong antifading mounting medium prior to fluores-
cence microscopy. For quantitative analyses, BUVEC
were treated with 3% NaN3 (5 min, RT) to inhibit
receptor recycling and washed with ice-cold PBS. Mono-
layers were detached by Accutase (Sigma-Aldrich) treat-
ment (5 min, 37 °C), washed in PBS (400 × g, 5 min) and
transferred to 5-mL FACS tubes containing 200 μL of
PBS. The cells were processed in a FACS Calibur flow cyt-
ometer using the FL1-H channel.
Real-time quantitative PCR assay for the detection of
cholesterol metabolism-associated molecules
Primers and probes (Biomers, Ulm, Germany) were
designed using Beacon Designer 7 (Premier Biosoft) and
Primer 3 (NCBI) software. In silico analyses were per-
formed to access primers and probes specificity [37].
Amplification efficiency of each qPCR assay was deter-
mined using linearized plasmids containing the respective
amplicon in pDrive (Qiagen). Only systems showing effi-
ciency values >0.9 were used. The sequences of primers
and probes and the efficiencies of each system are listed in
Table 1.
E. bovis-infected and control BUVEC (n = 3) were
processed for total RNA isolation at different time points
of macromeront maturation (days 12, 14, 17 and 20 pi).Total RNA isolation was performed using the RNeasy
kit (Qiagen) according to manufacturer’s protocol.
Therefore BUVEC were lysed within the cell culture
flasks with RLT lysis buffer (600 μL/25 cm2 flask) and
processed as proposed by the manufacturer. An on-column
DNase treatment (Qiagen) according to manufacturer’s
instruction was included in the total RNA isolation proced-
ure. Total RNAs were stored at −20 °C until further use.
The quality of total RNA samples was controlled via
Agilent 2100 bioanalyzer (Agilent Technologies, USA). In
order to remove any DNA leftover, a second genomic DNA
digestion step was performed. Therefore, 1 μg of total RNA
was treated with 10 U DNase I in 1x DNase reaction buffer
(all Thermo Scientific, 37 °C, 1 h). DNase was inactivated
by heating the sample (65 °C, 10 min). The efficiency of
genomic DNA digestion was controlled by including no-
RT-controls in each real-time PCR experiment.
cDNA synthesis was performed using the SuperScript
III First-Strand Synthesis System according to manufac-
turer’s protocol with slight modifications.1 μg of DNase-
treated total RNA was added to 1 μL of 50 μM oligo
d(T), 1 μL of 50 ng/μL random hexamer primer, 1 μL of
10 mM dNTP mix and DEPC-treated water was adjusted
to 10 μL total volume. The sample was incubated at 65 °C
for 5 min and then immediately cooled on ice. For first
strand cDNA synthesis, 2 μL of 10x RT buffer, 1 μL 25
mM MgCl2, 1 μL 0.1 M DTT, 1 μL RNaseOUT (40 U/μL)
and 1 μL SuperScript III enzyme (200 U/μL) were added
and the sample was incubated at 50 °C for 60 min
followed by a 85 °C-inactivation step for 15 min.
Real-time PCR was performed in duplicates in a 10 μL
total volume containing 400 nM forward and reverse
primers, 200 nM probe, 10 ng cDNA and 5 μL 2× PerfeCTa
qPCR FastMix (Quanta Biosciences, USA). The reaction
conditions for all systems were as follows: 95 °C for 10 min,
40 cycles at 95 °C for 10 s, 60 °C for 15 s and 72 °C for 30 s.
PCRs were performed on a Rotor-GeneQ cycler (Qiagen,
Hilden, Germany). No-template controls (NTC) and no-RT
reactions were included in each experiment. As a reference
gene we chose with GAPDH a gene that was previously
used in other publications reporting on E. bovis-infected
BUVEC [24,38]. To prove that the GAPDH gene is a suit-
able reference gene in this experimental set-up, we have
previously performed experiments on the stability of
GAPDH gene transcription in E. bovis-infected BUVEC.
Therefore, four different BUVEC isolates (=4 biological
replicates) were infected with E. bovis and tested for
GAPDH gene transcription (in duplicates) throughout
infection (at days 4, 8, 12, 14 and 17 pi). Considering all
samples of all isolates at Ct level we showed that GAPDH
gene transcription was not significantly influenced by the
infection (mean ± standard deviation of the Cts of all sam-
ples: 21.31 ± 0.84) but proved stabile within the kinetics,
since the variation of the data accounted to less than 4%.
Table 1 Sequences of primers and probes used in real-time qPCR
Symbol Name Accession
number
PCR
efficiency
Amplicon
length
Forward (5’→3’) Reverse (5’→3’) Probe (reporter 5’-3’ quencher)
ACAT1 Acetyl-CoA acetyltransferase 1 NM_001046075.1 0.95 102 TCATATGGGCAACTGTGCTGA CTGCTTTACTTCTGGTATAG FAM-AGCATAAGTATCCTGTTCCTCTCGTG-BHQ1
ACAT2 Acetyl-CoA acetyltransferase 2 NM_001075549.1 1.08 194 AGCAGTGGTTCTTATGAA AGGCTTCATTGATTTCAAA FAM-ATCAACATCCTCCAGCGACCA-BHQ1
HMGCS1 3-hydroxy-3-methylglutaryl-CoA
synthase 1
NM_001206578 0.93 197 CTACCTCAGTGCATTAGA CTCTGTTCTGGTCATTAAG HEX-AAGTCATTCAGCAACATCCGAGC-BHQ1
HMGCR 3-hydroxy-3-methylglutaryl-CoA
reductase
NM_001105613.1 0.94 109 GCCATCAACTGGATAGAG CCTCAATCATAGCCTCTG FAM-TCTCTGACAACCTTGGCTGGAAT-BHQ1
SQLE Squalene epoxidase NM_001098061.1 0.93 132 CCCTTCTTCACCAGTAAA CCCTTCAGCAATTTTCTC HEX-AACAACAGTCATTCCTCCACCAGTA-BHQ1
CH25H Cholesterol 25-hydroxylase NM_001075243.1 1.00 87 TTGGGTGTCTTTGACATG CAGCCAGATGTTGACAAC FAM-CGTCTTGCTGCTCCAGTGTC-BHQ1
SOAT1 Sterol O-acyltransferase 1
(SOAT1)
NM_001034206.2 0.93 99 GCCCTCCTCATTCTCTTC CCCAAAAGCATAAGACATGAG FAM-AGCACCAGCCTTCCTTCATCA-BHQ1
LDLR Low density lipoprotein receptor NM_001166530.1 1.00 96 CGCCTACCTCTTCTTTAC ACCACGTTCTTAAGGTTG FAM-TCGCTTCGGTCCAGAGTCATC-BHQ1
OLR1 Oxidized low density
lipoprotein/(lectin-like) receptor 1
NM_174132.2 0.97 102 CAAGCTGGATGAGAAATC GGACAAGGACCTGAATAG TET-ACTTCACCGCCAGAACCTGA-BHQ1
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
AF022183 0.98 82 GCGACACTCACTCTTCTACCTTCGA TCGTACCAGGAAATGAGCTTGAC FAM-CTGGCATTGCCCTCAACGACCACTT–BHQ1
H
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method (ΔΔCT method) and reported as n-fold differences
comparing E. bovis-infected BUVEC with non-infected
ones after normalizing the samples with the GAPDH
reference gene.
Merozoites I quantification via Eimeria bovis microneme
protein 4 (EbMIC4)-based real-time PCR
For merozoites I quantification we used a real-timePCR
system based on the detection of the single copy gene of
E. bovis microneme protein 4 (EbMIC4, [39]) applying
the following primers and probe: forward primer:
5’-CACAGAAAGCAAAAGACA-3’, reverse primer:
5’-GACCATTCTCCAAATTCC-3’ and probe: 5’-FAM-
CGCAGTCAGTCTTCTCCTTCC-BHQ1-3’ [26]. There-
fore, cell culture supernatants containing merozoites I
were collected at indicated time points pi. At the end
of the culture period the cells were trypsinized and
collected together with the supernatant followed by
centrifugation (600 × g, 15 min). The cell pellet was treated
with 200 μL of cell lysis buffer containing 0.32 M Sucrose,
1% Triton X-100, 0.01 M Tris-HCl (pH 7.5), 5 mM MgCl2
and incubated in 100 μL 1X PCR buffer (Quanta, USA)
containing 20 μL proteinase K (20 mg/mL; Qiagen) at
56 °C for 1 h. Proteinase K was heat-inactivated (95 °C,
10 min) and the DNA-containing samples were frozen
at − 20 °C until further use. All samples were processed
as triplicates.
Real-time PCR was performed in a total volume of
20 μL containing 5 μl DNA of merozoites I samples,
400 nM of each primer, 200 nM probe and 10 μL
PerfeCTa MasterMix (Quanta, USA) at 95 °C for 10 min;
40 cycles at 95 °C for 10 s, 60 °C for 15 s and 72 °C
for 30 s. In each PCR experiment serial dilutions of
merozoites I covering 6 magnitude orders of 10-fold
(106-10) were included allowing for absolute quantifi-
cation of merozoites I counts in the samples.
Statistics
Real-time PCR data analysis was performed by the ΔΔCT
method, normalized to GAPDH and expressed as rela-
tive fold change compared to control [40,41]. For statis-
tics data were analyzed by Student’s t-tests comparing
control and treated groups. GraphPad Prism 6.02 was
used to visualize graphs.
Results
Free cholesterol and neutral lipid/lipid droplet
distribution in E. bovis invasive stages
E. bovis sporozoites and merozoites I both were inten-
sively stained by filipin (Figures 1B, J, L). The strongest
reactions were detected at the apical part and in the
plasma membrane of these stages indicating high free
cholesterol contents in the apical complex and the pellicula(Figures 1B, J, L). In addition, an intense staining was
observed in the cytoplasm of sporozoites (Figure 1B).
These reactions may origin from intraparasitic organelle
membranes. Sporozoites and merozoites I of E. bovis also
showed an intense staining by Nile red (Figures 1G and
H) and Bodipy 493/503 (Figures 1D, N, P), indicating a
high content of neutral lipids/lipid droplets within these
stages. However, using Nile red we failed to demon-
strate structurally defined lipid droplet-like structures
within the cytoplasm of these stages, whilst Bodipy
493/503 staining resulted in strong fluorescent globu-
lar lipid body-like structures (Figures 1D and P). In mero-
zoites I and sporozoites lipid droplets were situated in the
cytoplasm and differed in numbers per specimen. Overall,
up to 8 lipid droplet-like structures were detected per in-
vasive stage. The overall strongest reactions upon Nile
red or Bodipy 493/503 staining were found in the
refractile bodies of the sporozoite stages (Figures 1D,
G, H, merozoites I do not contain any refractile bodies)
indicating the storage of neutral lipids within these spe-
cific apicomplexan organelles.
Cholesterol and lipid droplets accumulate in E. bovis-infected
cells during macromeront formation
One day after host cell infection, filipin-positive signals
accumulated very close to the parasites intracellular pos-
ition within the PV (Figure 2A). Compared to non-
infected control cells directly adjacent to infected host
cells, the cholesterol abundance was also significantly en-
hanced in immature and mature meronts I (Figure 2C).
Owing to the massive enlargement of the host cell leading
to a close position of the PV and host cell membrane, it
cannot be concluded whether the signals originate merely
from the parasite and its PVM or from the host cell mem-
brane or both. Total cholesterol quantification in lipid ex-
tracts revealed a significant increase of cholesterol
abundance in E. bovis-infected host cells over time when
compared to non-infected controls (Figure 2E; 4, 8 and 17
days pi vs. controls: all p < 0.01). Given that the cholesterol
content of sporozoites (here the individual infection
dose of 5 × 105 sporozoites was analyzed, Figure 2E)
was rather low, the changes of host cellular cholesterol
content could not be attributed to invading stages but to
infection-triggered alteration of the cholesterol metabolism.
Based on Bodipy 493/503 staining, a considerable
enhancement of lipid droplet formation was observed
with ongoing macromeront development (Figure 3).
The most significant accumulation of distinct lipid
droplet-like structures occurred in immature macro-
meronts (15-17 days pi, Figures 3A and 3C). The Bod-
ipy 493/503 staining was cross-checked with Nile red
staining (data not shown) which showed the same feature.
Alongside with macromeront maturation and merozoite I
formation, the fluorescence pattern changed from a spotty
Figure 1 Cholesterol and neutral lipid/lipid droplet localization in free E. bovis stages. Freshly excysted E. bovis sporozoites were stained by
filipin (A = phase contrast) and Bodipy 493/405 (C = phase contrast). Note the bright filipin signal in the apical part (*) and pellicula (B) and the
strong Bodipy 493/405 staining of the refractile bodies (rb) and cytosolic lipid droplets (ld) (D). Refractile bodies but no lipid droplets were stained in
sporozoites by Nile red (G, H = close-up, E/F = phase contrast). Merozoites I showed strong filipin-induced signals in the pellicula (J arrows, I = phase
contrast) and at the apical tips (L *, K= phase contrast). Bodipy 493/405 staining revealed cytosolic lipid droplets in merozoites I (N, P arrows; M, O= phase
contrast). Scale bars represent 5 μm.
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cloudy and diffuse reaction indicating that lipid droplet
contents were almost totally exhausted or consumed formerozoite I formation (Figure 3C). In order to better
define lipid droplet position, structure and size within E.
bovis-infected cells, confocal microscopic analyses were
Figure 2 Cholesterol distribution and cholesterol content in
E. bovis infected host endothelial cells. Bovine umbilical vein
endothelial cells (BUVEC) were infected with E. bovis sporozoites and
stained with filipin at one day (A; B = phase contrast, arrows indicate
sporozoites) and 17days (C; D = phase contrast) pi. Note the bright
filipin staining adjacent to intracellular sporozoites (A) and the strong
reactions in a meront I-carrying cell (C) compared to non-infected cells
in the neighborhood. For the quantification of the total cholesterol
contents (E), infected (black bars) and non-infected (grey bars) BUVEC
(n = 7) were harvested at different time points after infection (4, 8, 17
days pi), processed for total lipid extraction and total cholesterol
measurement using the Amplex Red® kit. Pure sporozoites (processed
numbers correspond to the infection dose) were used as controls.
Scale bars represent 10 μm.
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analyses of E. bovis-infected host cells 17 days pi revealed
the presence of bright fluorescent lipid droplets through-
out the macromeront corpus as demonstrated by the
detection in each layer (Z-stack) of the specimens (single
layer: Figure 3E, all layers see Additional file 1). Lipid
droplets showed classical globular shapes but were of
differing sizes. Whilst most lipid droplets were rathersmall (<1 μm), some of them revealed a size of more than
5 μm in diameter.
Given that the fixation mode may alter lipid droplet
integrity leading to dimmed LD appearance [42], we
additionally used osmium tetroxide staining which is
known to better preserve lipid body structures. However,
osmium tetroxide treatments led to similar results to
those of Bodipy 493/503 staining thus confirming the
significant increase of lipid droplet abundance (visible as
small black dots) in E. bovis macromeront-carrying host
cells (Figure 3F).
Applying FACS technology we additionally quantified the
changes of total lipid droplet contents in infected BUVEC
and control cells. FACS analyses revealed a significant
increase (2.8- and 6.6-fold at 17 and 21 days pi, respect-
ively) of total lipid droplet abundance of E. bovis-infected
BUVEC in times of macromeront formation resulting in
highly significant values for days 17 and 21 pi compared to
non-infected controls (both p ≤ 0.0001, Figure 4). These
data confirmed the microscopic observations described
above and underlined the relevance of lipid droplet forma-
tion during E. bovis macromeront development.
Extracellular sterol enrichment and enhanced cellular
lipid droplet disposability boost parasite replication
To assess the effects of exogenously supplied cholesterol on
E. bovis macromeront development, free sterols (cholesterol
and desmosterol) were administered to cell cultures.
Desmosterol is a cholesterol intermediate precursor
and can replace cholesterol function in sustaining cell
proliferation [43]. Owing to long term cytotoxicity we
could not supply cholesterol in the cyclodextrin-complexed
form and chose the very simple approach of supplementa-
tion in ethanol which had previously been shown to work
in T. gondii cultures [4] and according to Xu et al. [35]. To
avoid intracellular crystallization and cytotoxicity [35], low
concentrations (5 μM) of these substituents were applied.
We observed a significant beneficial effect on merozoite I
production leading to enhanced offspring generation in
both, cholesterol- and desmosterol-treated host cells when
compared to non-treated E. bovis-infected cultures
(Figure 5B, p ≤ 0.05). However, the infection rates and
macromeront sizes were not significantly altered by
cholesterol or desmosterol supplementation (Figure 5A).
Given that lipid droplets may play a pivotal role in E.
bovis in vitro development, we assessed the effects of an
artificially enhanced abundance of lipid droplets in
BUVEC. Therefore, BUVEC were treated with oleic acid,
a well-known inducer of lipid droplets formation in several
types of mammalian cells [36]. The microscopic control of
oleic acid-treated, infected BUVEC confirmed the lipid
droplet-boosting function of oleic acid treatments since
many more lipid droplets were found within the cytoplasm
of treated cells when compared to non-treated ones
Figure 3 Lipid droplet distribution in developing meronts. Bovine umbilical vein endothelial cells (BUVEC) were infected with E. bovis
sporozoites. For the illustration of lipid droplets, the cells (17 days pi) were either stained with Bodipy 493/503 and analyzed by conventional
fluorescence microscopy (A + C: Bodipy 493/503 (green), B +D: respective phase contrast illustrations) or confocal microscopy (E: Bodipy 493/503
(green), DNA staining via DAPI (blue); illustration in (E) was projected from 25 slices of Z-stack confocal analysis which is given in Additional file 1)
or subjected to osmium tetroxide staining (D including close-up). Note massive abundance of lipid droplets (green (Bodipy staining) or black (osmium
tetroxide) dots) within immature macromeronts (A, C, F) and the large sizes of lipid droplets (= ld, E). Note also that the cytoplasm of infected host
cells is free of lipid droplets (A, C). Scale bars represent 20 μm. nuc = nucleus of the host cell, cyt = cytoplasm of the host cell, PV = parasitophorous
vacuole, mac =macromeront-derived plasma membrane, imm= immature macromeront, mat =mature macromeront, ld = lipid droplet.
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lyses of merozoite I in vitro production in oleic acid-treated
and non-treated infected cells confirmed the key role of
lipid droplets in optimal parasite proliferation. Thus,
significant beneficial effects of oleic acid treatments on
merozoite I production were observed at all time points
of merozoite I quantification (Figure 6A; p ≤ 0.01 for
days 23; p ≤ 0.05 for days 26, 29, 30 pi). Referring to the
total merozoite I production, a 4.7 ± 2.9 fold increase of
offspring production was estimated.
E. bovis infection enhances surface LDL receptor
abundance on infected cells and exogenously supplied
LDL improves merozoite I production
To assess whether LDL binding to the cell surface is
altered in infected host cells, Bodipy-labelled LDL was
supplemented to in vitro cultures that had previouslybeen starved in LDL-free medium. LDL binding was
quantified using FACS technology. A significant increase
of Bodipy-LDL binding was detected in infected cells
versus non-infected controls (p < 0.0001, Figures 7A and
7B). Overall, a 37.5-fold enhancement was measured in
E. bovis-infected cells.
To estimate whether the increase in LDL-binding
originated from enhanced surface LDL receptor (LDLR)
abundance, a flow cytometry-based assay using an
LDLR-specific antibody was established and tested on
E. bovis-infected BUVEC at 17 days pi. Overall, the data
revealed a significant infection-induced increase of LDLR
surface expression (1.92 fold) in macromeront-carrying
host cells (infected vs. non-infected cells: p < 0.0001;
Figures 7C and 7D). These data are in agreement with
transcriptional profiles of LDLR in E. bovis-infected
cells, as described later (Figure 9).
Figure 4 Lipid droplet abundance in E. bovis-infected endothelial host cells. Bovine umbilical vein endothelial cells (BUVEC, n = 3) were
infected with E. bovis sporozoites. The cells were stained with Bodipy 493/503 to trace lipid droplets and subjected to flow cytometry analyses at
8, 17 and 21 days pi. Infected cells were assigned according to their size and granularity. A exemplary illustrations of histograms of Bodipy 493/
503-positive infected (black histogram) and non-infected (white histogram) BUVEC on days 8, 17 and 21 pi; (B) mean and standard deviations of
lipid droplet contents in infected host cells at 0, 8, 17 and 21 days pi.
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is enhanced in E. bovis-infected host cells, we then
investigated whether exogenous LDL supplementation
would be of benefit for E. bovis macromeront develop-
ment in vitro. Indeed, excess LDL stimulated E. bovis
merozoite I production. Although, macromeront sizes
and rates increased only slightly (Figure 8A), we observed
a significant increase of the total merozoite I production
after LDL supplementation (p < 0.01, Figure 8B) resulting
in a 1.54-fold enhancement of offspring synthesis.E. bovis infection induces up-regulation of the gene
transcription of molecules involved in the mevalonate
pathway and in cholesterol hydroxylation and esterification
Host cell de novo biosynthesis of cholesterol is a multistep
metabolic pathway involving more than 30 enzymatic
reactions. In these experiments transcriptional profiles of
several relevant molecules were analyzed during E. bovis
macromeront formation in vitro. For the formation of
acetoacetyl-CoA representing the substrate of the mevalo-
nate pathway, ACAT1/ACAT2 activities are needed [44].
Figure 5 E. bovis macromeront formation and merozoiteI production after cholesterol and desmosterol supplementation. E. bovis-infected
BUVEC (n = 5) were cultivated in non-supplemented (=controls) or cholesterol- and desmosterol-enriched medium. The effects on meront I formation
(A) were assessed microscopically by estimating the rate of meront I-carrying host cells (black bars: cholesterol-enriched medium, grey bars: desmosterol-
enriched medium, white bars: controls) and by measuring the sizes of developing meronts I (triangles: cholesterol-enriched medium, circles: desmosterol-
enriched medium, squares: controls). The effects on total merozoite Iproduction (B) were quantified via an EbMIC4-based qPCR after 30 days pi.
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during macromeront formation revealed the highest and
significant up-regulation for both molecules at 17 days pi
(p ≤ 0.01) indicating a high demand of acetoacetyl-CoA
when merozoites I are to be formed (Figure 9). Overall, the
up-regulation of ACAT1 gene transcription (maximum:
11.03 ± 2.53-fold) was higher than that of ACAT2
(maximum: 4.41 ± 2.1-fold). In addition, the gene tran-
scriptions of HMGCS1, HMGCR and SQLE were all
up-regulated during E. bovis macromeront formation
with significant reactions at 17 and 20 days pi (Figure 9,
HMGCS1: 17 days pi: p ≤ 0.05, 20 days pi p ≤ 0.01;
HMGCR: 14, 17 and 20 days pi: p ≤ 0.01; SQLE: 17 daysFigure 6 E. bovis merozoite I production after artificial lipid droplet ind
were cultivated in non-enriched (=controls, grey circles, A) or oleic acid-enriche
29 and 30 days pi) the numbers of merozoites I present in cell culture supernat
of a meront I- (indicated by a dotted circle) carrying, infected host cell (1
massive increase of lipid droplets in the cytoplasm of the host cell (cyt) api: p ≤ 0.01, 20 days pi: p ≤ 0.05). These data explicitly
indicate that E. bovis macromeront development signifi-
cantly interferes with the host cell de novo biosynthesis via
the mevalonate pathway. Given that all molecules were
equally found up-regulated, these reactions may reflect the
strong need of the parasite for excess cholesterol synthesis.
Following de novo biosynthesis, cholesterol may either
be recycled to the membranes or modified via further
enzymatic steps promoting hydroxylation via CH25H or
esterification via SOAT1 [45–47]. Analyses on E. bovis-in-
fected BUVEC revealed that both pathways of cholesterol
processing were significantly up-regulated at times of
macromeront formation. Thus, SOAT1 gene transcriptsuction via oleic acid supplementation. E. bovis-infected BUVEC (n = 3)
d (black circles, A) medium. At different time points after infection (23, 26,
ants (A) were quantified via an EbMIC4-based qPCR. B Exemplary illustration
7 days p. i.) being cultivated in oleic acid-enriched medium. Note the
nd in the meront. n = nucleus of the host cell.
Figure 7 LDL-binding and LDL surface receptor abundance on E. bovis-infected endothelial host cells. A-B: E. bovis-infected BUVEC and
non-infected controls were cultured in LDL-depleted medium for 36-48 h then incubated in medium containing Bodipy-labelled LDL. After incubation
at 4 °C for 1 h followed by 4 h of incubation at 37 °C, LDL binding was measured by FACS analysis: exemplary histogram (A) and LDL quantification in
infected (black bar, 17 days pi) and non-infected (white bar) cell layers. C-D: For the quantification of surface LDL receptors, infected (black bar 17 days
pi) and non-infected (white bar) cell layers were reacted with LDL receptor (LDLR)-specific primary antibodies and appropriate FITC-conjugated secondary
antibodies and subjected to flow cytometry analyses: exemplary histogram (C) and LDLR expression on the surface of E. bovis-infected (black bar, 17 days
pi) and non-infected (white bar) BUVEC.
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14 and 17 days pi (both: p ≤ 0.01), respectively, when com-
pared to non-infected controls (Figure 9). Given that
cholesterylesters are stored in lipid droplets, these results
indirectly confirmed the data on enhanced lipid droplet
formation in E. bovis-infected host cells. The overall
strongest up-regulation of all gene transcripts tested
was measured for CH25H (Figure 9). Hence, significant
enhancements of gene transcription were detected at days
14, 17 (both: p ≤ 0.001) and 20 (p ≤ 0.01) pi, suggesting acrucial role of 25-hydroxycholesterol synthesis in the
development of E. bovis macromeronts.
The transcriptional profiling of LDLR and OLR1 in E.
bovis-infected host cells additionally showed significantly
enhanced mRNA levels for both molecules. Compared
to non-infected controls, significant reactions were detected
for LDLR at 12 and 17 days pi (both: p ≤ 0.01) reaching an
up to 9.49-fold increase (Figure 9). OLR1 gene transcripts
were significantly enhanced during the entire period of
investigation (days 12, 17 and 20 pi: p ≤ 0.01, day 14 pi:
Figure 8 E. bovis macromeront formation and merozoite I production after LDL supplementation. E. bovis-infected BUVEC (n = 5) were
grown in non-enriched (=controls) or LDL-enriched medium. The effects of LDL supplementation on macromeront formation (A) were assessed
microscopically by estimating the rate of macromeront-carrying host cells (black bars: LDL-enriched medium, white bars: controls) and by measuring the
size of developing macromeronts (black circles: LDL-enriched medium; white circles: controls). The effects of LDL supplementation on total merozoite I
production (B) were quantified via a EbMIC4-based qPCR at 30 days pi.
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crease in E. bovis infected cells.
Discussion
During first merogony E. bovis forms the PV, enlarges
the endothelial host cell and produces thousands of mer-
ozoites I and, consequently, is in considerable need for
cholesterol. We here show that the parasite significantly
utilizes different host cellular cholesterol acquisition
pathways and demonstrate that E. bovis-induced modu-
lation of the host cell cholesterol metabolism differs
from other apicomplexan parasites for several reasons:
i) the massive induction of lipid droplets within the
immature meront I stage, ii) the simultaneous interfer-
ence with both, the host cellular de novo synthesis
and LDL-mediated cholesterol up-take, iii) the involve-
ment of OLR1 and iv) the induction of CH25H in host
cellular cholesterol modification.
In contrast to other apicomplexan parasites, such as T.
gondii, the monoxenous protozoa E. bovis represents a
strict host- and host cell-specific parasite. Thus, first
merogony exclusively occurs in bovine endothelial cells
and lasts for up to three weeks. Filipin staining experi-
ments ascertained that E. bovis stages indeed do contain
free cholesterol molecules. This is in line with tachy-
zoites of T. gondii, [4,47–49] but in contrast to P. yoelii
free sporozoites which lack filipin staining [6]. Early after
infection and in cells carrying developing macromeronts
strong filipin reaction were observed indicating high
cholesterol contents in infected cells. Quantitative analysesrevealed an almost doubling of total cholesterol content in
times of E. bovis macromeront maturation. Furthermore
and in accordance to studies on T. gondii [4], excess
exogenous cholesterol resulted in significantly enhanced
offspring production confirming the key role of high chol-
esterol abundance for successful E. bovis development.
Neutral lipid staining in E. bovis free stages revealed a
differential distribution of free cholesterol and neutral
lipids in sporozoites and merozoites I. Thus, neutral
lipids exclusively occurred in the refractile bodies of
sporozoites and in cytosolic lipid droplet-like struc-
tures of both stages. This is in line with observations
on E. tenella sporozoites [50,51] and T. gondii tachy-
zoites [4,12,15].
The most striking feature in E. bovis-infected host cells
was the massive induction of lipid droplets within the
immature meront I (note that the cytoplasm did not
show any lipid droplets) which finds no correlate in
any other coccidian infection. Although a stage-
dependent increase of lipid droplets was also reported in
P. falciparum-infected erythrocytes [19–21], these organ-
elles were mainly localized in the host cell cytoplasm and
not within the parasitic stages and were of much less
numbers. Interestingly, the maximum lipid droplet gener-
ation was observed in late immature macromeronts, i.e. at
times when merozoites I are about to be formed. In con-
trast, in mature macromeronts carrying fully developed
merozoites I, structurally defined lipid droplets were
hardly observed, suggesting that lipid droplet contents
were almost totally consumed during offspring formation.
Figure 9 Gene transcription of molecules involved in cholesterol de novo synthesis and cholesterol esterification and hydroxylation in
E. bovis-infected endothelial host cells. Total RNA was isolated from E. bovis-infected BUVEC (n = 3) at different time points of macromeront
formation (12, 14, 17 and 20 days pi), reverse transcribed and subjected to quantitative real-time PCR assays for the detection of bovine acetyl-CoA
acyl transferase 1 (ACAT1), acetyl-CoA acyl transferase 2 (ACAT2), HMG-CoA synthase 1 (HMGCS1), HMG-CoA reductase (HMGCR), squalene epoxidase
(SQLE), sterol O-acyltransferase 1 (SOAT1), cholesterol 25-hydroxylase (CH25H), low density lipoprotein receptor (LDLR) and oxidized low density lipoprotein
receptor 1 (OLR1). Non-infected BUVEC were equally processed at each time point of the experiments and served as negative controls.* = p≤ 0.05,
** = p≤ 0.01, *** = p≤ 0.0001.
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tions of lipid droplet sizes in macromeront-carrying host
cells, ranging from submicrometer diameters to large sizes
of ≥5 μm. Accordingly, “gigantic” lipid droplets (being situ-
ated within the host cell cytoplasm) were previously de-
scribed in Trypanosomacruzi-infected host cells [52] but
not in any other coccidian parasite, so far. The general
phenomenon of enhanced lipid droplet formation in in-
fected host cells was also reported for other protozoan
parasites such as T. cruzi, T. gondii, P. berghei or P. falcip-
arum [16,18,19,52–54]. However, it has to be stressed that
the localization and the degree of lipid droplet formation
in the latter cases was not at all comparable to E. bovis
infections and most reports referred to host cell cytosoliclipid droplets and not parasitic ones. Whilst in T. cruzi-,
T. gondii- or P. falciparum-induced host cell lipid droplets
never exceeded a number of ~20 [16,19,55], the numbers
of these organelles was 100-1000-fold higher in immature
E. bovis meronts (suspected numbers since the true num-
bers are uncountable owing to the thickness of the speci-
mens). The key role of lipid droplets was furthermore
proven by oleic acid treatments which significantly im-
proved parasite proliferative capacities. Given that excess
cellular cholesterol is stored in the esterified form in lipid
droplets, we additionally analyzed the gene transcription of
SOAT1, i.e., the enzyme promoting cholesterol esterifica-
tion, and demonstrated a significant increase of respective
transcripts in E. bovis-infected cells. In line with other
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esterification for optimal E. bovis proliferation cells was
recently confirmed by chemical SOAT inhibition leading
to almost total blockage of E. bovis replication in endothe-
lial host cells [37].
Besides esterification, hydroxylation of cholesterol is
also performed to detoxify this molecule in mammalian
cells. Transcriptional profiling and protein expression
(P. Hamid, personal communication) analyses of E. bovis-
infected BUVEC showed a significant up-regulation of
CH25H which promotes cholesterol hydroxylation. It is
noteworthy, that the overall highest up-regulation of gene
transcripts and proteins concerned CH25H suggesting
enhanced 25-OH-cholesterol (25-OHC) synthesis to occur
in E. bovis-infected host cells. So far, no comparable
phenomenon was reported in any other coccidian parasite
infection. It has to be mentioned that levels of gene tran-
scription and protein expression do not necessarily reflect
cellular enzyme activities. However, preliminary results on
biochemical 25-OHC measurements showed enhanced
concentrations of this molecule in E. bovis-infected host
cells (A. Taubert, unpublished data) indicating a new
strategy of cholesterol processing in coccidian-infected
host cells.
Transcriptional profiling of E. bovis-infected host cells
showed that all molecules tested being involved in the
mevalonate pathway or in early substrate synthesis were
found up-regulated in times of merozoite I formation.
An enhancement of ACAT1 was also confirmed on the
protein level (P. Hamid, personal communication). These
data are in line with recent data on chemical HMGCS1
and SQLE inhibition leading to a significant blockage of E.
bovis proliferation [26]. Related data in T. gondii infections
are somewhat conflicting: whilst Coppens et al. [4] denied
any involvement of this pathway in T. gondii-infected host
cells, other studies indicated that de novo synthesis indeed
contributes to T. gondii growth [10,11,56].
Besides de novo biosynthesis, exogenous cholesterol is
acquired via cellular lipoprotein internalization. LDL has
been reported as major exogenous cholesterol source for
T. gondii, C. parvum and Plasmodium spp. [4,6,7].
Accordingly, we here report on enhanced binding and
up-take of LDL at times of E. bovis macromeront forma-
tion. Consistent with recent microarray data [25], LDLR
gene transcripts were found significantly up-regulated
throughout E. bovis macromeront development. Further-
more, a significant increase of surface LDLR abundance
was detected on infected host cells via FACS analyses.
These results are in line with data on T. gondii-infected
CHO cells [4], but contrast to the fact that reduced
LDLR expression did not affect the liver stage burden in
the case of Plasmodium spp. [6]. In accordance to T.
gondii-infected CHO cells [4], LDL supplementation had
beneficial effects on E. bovis merozoite I productionconfirming the pivotal role of LDL for optimal parasite
replication. In contrast, LDL enrichment had no stimula-
tory effects on Plasmodium spp. and C. parvum prolifer-
ation [6,7] or on T. gondii growth in macrophages [10]
indicating parasite- and cell type-specific mechanisms.
The current transcriptional data additionally revealed
the scavenger receptor OLR1 (syn. LOX-1) to be involved
in E. bovis-triggered LDL-uptake since a strong up-
regulation of this receptor was detected in times of macro-
meront formation. These data are in agreement with
recent microarray data [25] and were confirmed on
protein level (P. Hamid, personal observation.). OLR1
is considered as the major receptor for oxidized LDL
(oxLDL) internalization in vascular endothelial cells
[57–59]. To our knowledge, this represents the first
report indicating an involvement of OLR1/oxLDL in
coccidian host cell infections.
Overall, the current data indicate that E. bovis has the
capacity to scavenge cholesterol from several cellular
sources at a time, which clearly contrasts to T. gondii
[4]. Given that cellular cholesterol synthesis is tightly
regulated by a complex network of cellular mechanisms,
more research is needed to understand how E. bovis out-
wits this regulatory network.
Additional file
Additional file 1: Confocal sections of lipid droplet accumulation in
a macromeront. 25 confocal sections of the composite Z-stack shown in
Figure 3E are depicted. Nuclei were stained by DAPI (blue) whilst lipid droplets
were shown in green by Bodipy 493/503 staining. Scale bars represent: 10 μm.
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